Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Kiener Peter A
Relationship:   Director
City:   Gaithersburg
State:   MD
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   357    

Indirect Shares

  0      
Direct Value   $760    

Indirect Value

  $0      
Total Shares   357      
Total Value   $760      


Cue Biopharma, Inc.
 $760 Cue Biopharma, Inc.
 $760
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    1    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -6.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Medimmune Inc MEDI SVP, Research 2006-02-08 0 2006-02-08 0    Premium*  
            Sucampo Pharmaceuticals, Inc. SCMP Chief Science Officer 2018-02-13 0 2016-03-31 0    Premium*  
            Cue Biopharma, Inc. CUE Director 2023-03-23 357 2021-11-15 0    Premium*  
* Premium Members only  

Records found :    21         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
CUE Cue Biopharma, Inc. Director   –       •      –    2023-03-23 4 S $3.28 $30,586 D/D (9,325) 357 0 %
CUE Cue Biopharma, Inc. Director   –       •      –    2023-03-23 4 OE $2.86 $27,691 D/D 9,682 9,682 0 -
CUE Cue Biopharma, Inc. Director   –       •      –    2021-11-16 4 AS $18.02 $24,525 D/D (1,361) 0 0 %
CUE Cue Biopharma, Inc. Director   –       •      –    2021-11-16 4 OE $2.86 $3,892 D/D 1,361 1,361 0 -
CUE Cue Biopharma, Inc. Director   –       •      –    2021-11-15 4 OE $2.86 $53,811 D/D 18,815 18,815 0 -
CUE Cue Biopharma, Inc. Director   –       •      –    2021-11-15 4 AS $17.92 $337,165 D/D (18,815) 0 0 %
SCMP Sucampo Pharmaceuticals, ... Chief Science Officer   •       –      –    2018-02-13 4 D $18.00 $807,408 D/D (44,856) 0 0 -
SCMP Sucampo Pharmaceuticals, ... Chief Science Officer   •       –      –    2017-12-31 4 A $9.10 $2,994 D/D 329 44,856 0 -
SCMP Sucampo Pharmaceuticals, ... Chief Science Officer   •       –      –    2017-12-28 4 D $17.98 $494,378 D/D (27,496) 44,527 0 -
SCMP Sucampo Pharmaceuticals, ... Chief Science Officer   •       –      –    2017-12-07 4 AS $16.50 $825,000 D/D (50,000) 2,023 0 -
SCMP Sucampo Pharmaceuticals, ... Chief Science Officer   •       –      –    2017-12-07 4 OE $8.33 $416,500 D/D 50,000 52,023 0 -
SCMP Sucampo Pharmaceuticals, ... Chief Science Officer   •       –      –    2017-09-30 4 A $9.10 $3,003 D/D 330 2,023 0 -
SCMP Sucampo Pharmaceuticals, ... Chief Science Officer   •       –      –    2017-06-30 4 A $8.93 $3,000 D/D 336 1,693 0 -
SCMP Sucampo Pharmaceuticals, ... Chief Science Officer   •       –      –    2017-03-31 4 A $9.35 $3,001 D/D 321 1,357 0 -
SCMP Sucampo Pharmaceuticals, ... Chief Scientific Officer   •       –      –    2017-03-06 4 A $0.00 $0 D/D 70,000 70,000 0 -
SCMP Sucampo Pharmaceuticals, ... Chief Scientific Officer   •       –      –    2016-12-31 4 A $10.46 $3,002 D/D 287 1,036 0 -
SCMP Sucampo Pharmaceuticals, ... Chief Scientific Officer   •       –      –    2016-09-30 4 A $9.38 $3,002 D/D 320 749 0 -
SCMP Sucampo Pharmaceuticals, ... Chief Scientific Officer   •       –      –    2016-06-30 4 A $9.32 $2,796 D/D 300 429 0 -
SCMP Sucampo Pharmaceuticals, ... Chief Scientific Officer   •       –      –    2016-03-31 4 A $9.29 $1,198 D/D 129 129 0 -
MEDI Medimmune Inc SVP, Research   •       –      –    2006-02-08 4 S $33.41 $400,955 D/D (12,000) 0 -
MEDI Medimmune Inc SVP, Research   •       –      –    2006-02-08 4 OE $23.45 $281,400 D/D 12,000 12,000 -

  21  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed